Vext Science Statistics
Total Valuation
Vext Science has a market cap or net worth of 55.49 million. The enterprise value is 86.12 million.
Market Cap | 55.49M |
Enterprise Value | 86.12M |
Important Dates
The last earnings date was Wednesday, August 20, 2025.
Earnings Date | Aug 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 180.31M |
Shares Outstanding | n/a |
Shares Change (YoY) | +19.39% |
Shares Change (QoQ) | +0.04% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 175.29M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.26 |
PB Ratio | 0.78 |
P/TBV Ratio | n/a |
P/FCF Ratio | 6.42 |
P/OCF Ratio | 5.03 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.27, with an EV/FCF ratio of 9.96.
EV / Earnings | -5.21 |
EV / Sales | 1.98 |
EV / EBITDA | 21.27 |
EV / EBIT | n/a |
EV / FCF | 9.96 |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.50.
Current Ratio | 0.94 |
Quick Ratio | 0.31 |
Debt / Equity | 0.50 |
Debt / EBITDA | 4.25 |
Debt / FCF | 4.12 |
Interest Coverage | -2.04 |
Financial Efficiency
Return on equity (ROE) is -20.91% and return on invested capital (ROIC) is -3.86%.
Return on Equity (ROE) | -20.91% |
Return on Assets (ROA) | -3.23% |
Return on Invested Capital (ROIC) | -3.86% |
Return on Capital Employed (ROCE) | -6.30% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.32 |
Inventory Turnover | 2.96 |
Taxes
In the past 12 months, Vext Science has paid 3.30 million in taxes.
Income Tax | 3.30M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.12% in the last 52 weeks. The beta is 1.37, so Vext Science's price volatility has been higher than the market average.
Beta (5Y) | 1.37 |
52-Week Price Change | +23.12% |
50-Day Moving Average | 0.16 |
200-Day Moving Average | 0.12 |
Relative Strength Index (RSI) | 64.59 |
Average Volume (20 Days) | 37,068 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vext Science had revenue of 44.15 million and -16.52 million in losses. Loss per share was -0.07.
Revenue | 44.15M |
Gross Profit | 13.24M |
Operating Income | -7.18M |
Pretax Income | -13.22M |
Net Income | -16.52M |
EBITDA | 7.46M |
EBIT | -7.18M |
Loss Per Share | -0.07 |
Balance Sheet
The company has 4.55 million in cash and 35.62 million in debt, giving a net cash position of -31.07 million.
Cash & Cash Equivalents | 4.55M |
Total Debt | 35.62M |
Net Cash | -31.07M |
Net Cash Per Share | n/a |
Equity (Book Value) | 71.04M |
Book Value Per Share | 0.29 |
Working Capital | -1.18M |
Cash Flow
In the last 12 months, operating cash flow was 11.03 million and capital expenditures -2.38 million, giving a free cash flow of 8.65 million.
Operating Cash Flow | 11.03M |
Capital Expenditures | -2.38M |
Free Cash Flow | 8.65M |
FCF Per Share | n/a |
Margins
Gross margin is 29.99%, with operating and profit margins of -16.25% and -37.42%.
Gross Margin | 29.99% |
Operating Margin | -16.25% |
Pretax Margin | -29.95% |
Profit Margin | -37.42% |
EBITDA Margin | 16.89% |
EBIT Margin | -16.25% |
FCF Margin | 19.59% |
Dividends & Yields
Vext Science does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -19.39% |
Shareholder Yield | n/a |
Earnings Yield | -29.78% |
FCF Yield | 15.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Vext Science has an Altman Z-Score of 0.57 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.57 |
Piotroski F-Score | 4 |